+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Overactive Bladder Therapeutics Market 2025-2029- Product Image
Overactive Bladder Therapeutics Market 2025-2029- Product Image
New

Overactive Bladder Therapeutics Market 2025-2029

  • PDF Icon

    Report

  • 221 Pages
  • May 2025
  • Region: Global
  • TechNavio
  • ID: 6092574
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The overactive bladder therapeutics market is forecasted to grow by USD 901.9 million during 2024-2029, accelerating at a CAGR of 4% during the forecast period. The report on the overactive bladder therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by aging population, rising prevalence of oab, and expansion of healthcare infrastructure.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

The overactive bladder therapeutics market is segmented as below:

By Product

  • Anticholinergics
  • Beta-3 adrenergic agonists
  • Others

By Distribution Channel

  • Retail pharmacies
  • Hospital pharmacies
  • Online

By Disease Type

  • Idiopathic overactive bladder
  • Neurogenic overactive bladder

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the adoption of minimally invasive treatments as one of the prime reasons driving the overactive bladder therapeutics market growth during the next few years. Also, increasing focus on awareness campaigns and increasing number of clinical trials will lead to sizable demand in the market.

The report on the overactive bladder therapeutics market covers the following areas:

  • Overactive Bladder Therapeutics Market sizing
  • Overactive Bladder Therapeutics Market forecast
  • Overactive Bladder Therapeutics Market industry analysis
A robust vendor analysis within the report is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading overactive bladder therapeutics market vendors that include AbbVie Inc., Apotex Inc., Astellas Pharma Inc., Aurobindo Pharma Ltd., Axonics Inc., Dr Reddys Laboratories Ltd., Ferring BV, Imbrium Therapeutics L.P, Johnson and Johnson Services Inc., Lipella Pharmaceuticals Inc., Lupin Ltd., Medtronic Plc, Medytox, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc., Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc. Also, the overactive bladder therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Distribution Channel
Executive Summary - Chart on Market Segmentation by Disease Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Analysis
2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
Overview on factors of disruption
2.4 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
3.1 Market ecosystem
Parent Market
Data Table on - Parent Market
3.2 Market characteristics
Market characteristics analysis
3.3 Value chain analysis
Value chain analysis
4 Market Sizing
4.1 Market definition
Offerings of companies included in the market definition
4.2 Market segment analysis
Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
Chart on Global - Market size and forecast 2024-2029 ($ million)
Data Table on Global - Market size and forecast 2024-2029 ($ million)
Chart on Global Market: Year-over-year growth 2024-2029 (%)
Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
5.1 Global Overactive Bladder Therapeutics Market 2019 - 2023
Historic Market Size - Data Table on Global Overactive Bladder Therapeutics Market 2019 - 2023 ($ million)
5.2 Product segment analysis 2019 - 2023
Historic Market Size - Product Segment 2019 - 2023 ($ million)
5.3 Distribution Channel segment analysis 2019 - 2023
Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
5.4 Disease Type segment analysis 2019 - 2023
Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
6.1 Impact Analysis of U.S. Tariffs on Global Overactive Bladder Therapeutics Market
7 Five Forces Analysis
7.1 Five forces summary
Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Product
8.1 Market segments
Chart on Product - Market share 2024-2029 (%)
Data Table on Product - Market share 2024-2029 (%)
8.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
8.3 Anticholinergics - Market size and forecast 2024-2029
Chart on Anticholinergics - Market size and forecast 2024-2029 ($ million)
Data Table on Anticholinergics - Market size and forecast 2024-2029 ($ million)
Chart on Anticholinergics - Year-over-year growth 2024-2029 (%)
Data Table on Anticholinergics - Year-over-year growth 2024-2029 (%)
8.4 Beta-3 adrenergic agonists - Market size and forecast 2024-2029
Chart on Beta-3 adrenergic agonists - Market size and forecast 2024-2029 ($ million)
Data Table on Beta-3 adrenergic agonists - Market size and forecast 2024-2029 ($ million)
Chart on Beta-3 adrenergic agonists - Year-over-year growth 2024-2029 (%)
Data Table on Beta-3 adrenergic agonists - Year-over-year growth 2024-2029 (%)
8.5 Others - Market size and forecast 2024-2029
Chart on Others - Market size and forecast 2024-2029 ($ million)
Data Table on Others - Market size and forecast 2024-2029 ($ million)
Chart on Others - Year-over-year growth 2024-2029 (%)
Data Table on Others - Year-over-year growth 2024-2029 (%)
8.6 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
9 Market Segmentation by Distribution Channel
9.1 Market segments
Chart on Distribution Channel - Market share 2024-2029 (%)
Data Table on Distribution Channel - Market share 2024-2029 (%)
9.2 Comparison by Distribution Channel
Chart on Comparison by Distribution Channel
Data Table on Comparison by Distribution Channel
9.3 Retail pharmacies - Market size and forecast 2024-2029
Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
9.4 Hospital pharmacies - Market size and forecast 2024-2029
Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
9.5 Online - Market size and forecast 2024-2029
Chart on Online - Market size and forecast 2024-2029 ($ million)
Data Table on Online - Market size and forecast 2024-2029 ($ million)
Chart on Online - Year-over-year growth 2024-2029 (%)
Data Table on Online - Year-over-year growth 2024-2029 (%)
9.6 Market opportunity by Distribution Channel
Market opportunity by Distribution Channel ($ million)
Data Table on Market opportunity by Distribution Channel ($ million)
10 Market Segmentation by Disease Type
10.1 Market segments
Chart on Disease Type - Market share 2024-2029 (%)
Data Table on Disease Type - Market share 2024-2029 (%)
10.2 Comparison by Disease Type
Chart on Comparison by Disease Type
Data Table on Comparison by Disease Type
10.3 Idiopathic overactive bladder - Market size and forecast 2024-2029
Chart on Idiopathic overactive bladder - Market size and forecast 2024-2029 ($ million)
Data Table on Idiopathic overactive bladder - Market size and forecast 2024-2029 ($ million)
Chart on Idiopathic overactive bladder - Year-over-year growth 2024-2029 (%)
Data Table on Idiopathic overactive bladder - Year-over-year growth 2024-2029 (%)
10.4 Neurogenic overactive bladder - Market size and forecast 2024-2029
Chart on Neurogenic overactive bladder - Market size and forecast 2024-2029 ($ million)
Data Table on Neurogenic overactive bladder - Market size and forecast 2024-2029 ($ million)
Chart on Neurogenic overactive bladder - Year-over-year growth 2024-2029 (%)
Data Table on Neurogenic overactive bladder - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by Disease Type
Market opportunity by Disease Type ($ million)
Data Table on Market opportunity by Disease Type ($ million)
11 Customer Landscape
11.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
12.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2024-2029 (%)
Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
12.3 North America - Market size and forecast 2024-2029
Chart on North America - Market size and forecast 2024-2029 ($ million)
Data Table on North America - Market size and forecast 2024-2029 ($ million)
Chart on North America - Year-over-year growth 2024-2029 (%)
Data Table on North America - Year-over-year growth 2024-2029 (%)
12.4 Europe - Market size and forecast 2024-2029
Chart on Europe - Market size and forecast 2024-2029 ($ million)
Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Chart on Europe - Year-over-year growth 2024-2029 (%)
Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
Chart on Asia - Market size and forecast 2024-2029 ($ million)
Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Chart on Asia - Year-over-year growth 2024-2029 (%)
Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 US - Market size and forecast 2024-2029
Chart on US - Market size and forecast 2024-2029 ($ million)
Data Table on US - Market size and forecast 2024-2029 ($ million)
Chart on US - Year-over-year growth 2024-2029 (%)
Data Table on US - Year-over-year growth 2024-2029 (%)
12.8 China - Market size and forecast 2024-2029
Chart on China - Market size and forecast 2024-2029 ($ million)
Data Table on China - Market size and forecast 2024-2029 ($ million)
Chart on China - Year-over-year growth 2024-2029 (%)
Data Table on China - Year-over-year growth 2024-2029 (%)
12.9 Germany - Market size and forecast 2024-2029
Chart on Germany - Market size and forecast 2024-2029 ($ million)
Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Chart on Germany - Year-over-year growth 2024-2029 (%)
Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.10 India - Market size and forecast 2024-2029
Chart on India - Market size and forecast 2024-2029 ($ million)
Data Table on India - Market size and forecast 2024-2029 ($ million)
Chart on India - Year-over-year growth 2024-2029 (%)
Data Table on India - Year-over-year growth 2024-2029 (%)
12.11 UK - Market size and forecast 2024-2029
Chart on UK - Market size and forecast 2024-2029 ($ million)
Data Table on UK - Market size and forecast 2024-2029 ($ million)
Chart on UK - Year-over-year growth 2024-2029 (%)
Data Table on UK - Year-over-year growth 2024-2029 (%)
12.12 Canada - Market size and forecast 2024-2029
Chart on Canada - Market size and forecast 2024-2029 ($ million)
Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Chart on Canada - Year-over-year growth 2024-2029 (%)
Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.13 France - Market size and forecast 2024-2029
Chart on France - Market size and forecast 2024-2029 ($ million)
Data Table on France - Market size and forecast 2024-2029 ($ million)
Chart on France - Year-over-year growth 2024-2029 (%)
Data Table on France - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
Chart on Japan - Market size and forecast 2024-2029 ($ million)
Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Chart on Japan - Year-over-year growth 2024-2029 (%)
Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 Brazil - Market size and forecast 2024-2029
Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Chart on Brazil - Year-over-year growth 2024-2029 (%)
Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.16 South Korea - Market size and forecast 2024-2029
Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Chart on South Korea - Year-over-year growth 2024-2029 (%)
Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints
14 Competitive Landscape
14.1 Overview
14.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
Overview on factors of disruption
14.4 Industry risks
Impact of key risks on business
15 Competitive Analysis
15.1 Companies profiled
Companies covered
15.2 Company ranking index
Company ranking index
15.3 Market positioning of companies
Matrix on companies position and classification
15.4 AbbVie Inc.
AbbVie Inc. - Overview
AbbVie Inc. - Product / Service
AbbVie Inc. - Key news
AbbVie Inc. - Key offerings
SWOT
15.5 Apotex Inc.
Apotex Inc. - Overview
Apotex Inc. - Product / Service
Apotex Inc. - Key news
Apotex Inc. - Key offerings
SWOT
15.6 Astellas Pharma Inc.
Astellas Pharma Inc. - Overview
Astellas Pharma Inc. - Product / Service
Astellas Pharma Inc. - Key offerings
SWOT
15.7 Aurobindo Pharma Ltd.
Aurobindo Pharma Ltd. - Overview
Aurobindo Pharma Ltd. - Product / Service
Aurobindo Pharma Ltd. - Key offerings
SWOT
15.8 Axonics Inc.
Axonics Inc. - Overview
Axonics Inc. - Business segments
Axonics Inc. - Key offerings
Axonics Inc. - Segment focus
SWOT
15.9 Dr Reddys Laboratories Ltd.
Dr Reddys Laboratories Ltd. - Overview
Dr Reddys Laboratories Ltd. - Business segments
Dr Reddys Laboratories Ltd. - Key news
Dr Reddys Laboratories Ltd. - Key offerings
Dr Reddys Laboratories Ltd. - Segment focus
SWOT
15.10 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
SWOT
15.11 Lupin Ltd.
Lupin Ltd. - Overview
Lupin Ltd. - Business segments
Lupin Ltd. - Key news
Lupin Ltd. - Key offerings
Lupin Ltd. - Segment focus
SWOT
15.12 Medtronic Plc
Medtronic Plc - Overview
Medtronic Plc - Business segments
Medtronic Plc - Key news
Medtronic Plc - Key offerings
Medtronic Plc - Segment focus
SWOT
15.13 Merck and Co. Inc.
Merck and Co. Inc. - Overview
Merck and Co. Inc. - Business segments
Merck and Co. Inc. - Key news
Merck and Co. Inc. - Key offerings
Merck and Co. Inc. - Segment focus
SWOT
15.14 Ono Pharmaceutical Co. Ltd.
Ono Pharmaceutical Co. Ltd. - Overview
Ono Pharmaceutical Co. Ltd. - Product / Service
Ono Pharmaceutical Co. Ltd. - Key offerings
SWOT
15.15 Pfizer Inc.
Pfizer Inc. - Overview
Pfizer Inc. - Product / Service
Pfizer Inc. - Key news
Pfizer Inc. - Key offerings
SWOT
15.16 Sumitomo Pharma Co. Ltd.
Sumitomo Pharma Co. Ltd. - Overview
Sumitomo Pharma Co. Ltd. - Business segments
Sumitomo Pharma Co. Ltd. - Key offerings
Sumitomo Pharma Co. Ltd. - Segment focus
SWOT
15.17 Sun Pharmaceutical Industries Ltd.
Sun Pharmaceutical Industries Ltd. - Overview
Sun Pharmaceutical Industries Ltd. - Product / Service
Sun Pharmaceutical Industries Ltd. - Key news
Sun Pharmaceutical Industries Ltd. - Key offerings
SWOT
15.18 Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. - Overview
Teva Pharmaceutical Industries Ltd. - Business segments
Teva Pharmaceutical Industries Ltd. - Key news
Teva Pharmaceutical Industries Ltd. - Key offerings
Teva Pharmaceutical Industries Ltd. - Segment focus
SWOT
16 Appendix
16.1 Scope of the report
16.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
16.3 Currency conversion rates for US$
Currency conversion rates for US$
16.4 Research methodology
Research methodology
16.5 Data procurement
Information sources
16.6 Data validation
Data validation
16.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
16.8 Data synthesis
Data synthesis
16.9 360 degree market analysis
360 degree market analysis
16.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits 7: Executive Summary - Chart on Market Segmentation by Disease Type
Exhibits 8: Executive Summary - Chart on Incremental Growth
Exhibits 9: Executive Summary - Data Table on Incremental Growth
Exhibits 10: Executive Summary - Chart on Company Market Positioning
Exhibits 11: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 12: Overview on criticality of inputs and factors of differentiation
Exhibits 13: Overview on factors of disruption
Exhibits 14: Impact of drivers and challenges in 2024 and 2029
Exhibits 15: Parent Market
Exhibits 16: Data Table on - Parent Market
Exhibits 17: Market characteristics analysis
Exhibits 18: Value chain analysis
Exhibits 19: Offerings of companies included in the market definition
Exhibits 20: Market segments
Exhibits 21: Chart on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 22: Data Table on Global - Market size and forecast 2024-2029 ($ million)
Exhibits 23: Chart on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 24: Data Table on Global Market: Year-over-year growth 2024-2029 (%)
Exhibits 25: Historic Market Size - Data Table on Global Overactive Bladder Therapeutics Market 2019 - 2023 ($ million)
Exhibits 26: Historic Market Size - Product Segment 2019 - 2023 ($ million)
Exhibits 27: Historic Market Size - Distribution Channel Segment 2019 - 2023 ($ million)
Exhibits 28: Historic Market Size - Disease Type Segment 2019 - 2023 ($ million)
Exhibits 29: Historic Market Size - Geography Segment 2019 - 2023 ($ million)
Exhibits 30: Historic Market Size - Country Segment 2019 - 2023 ($ million)
Exhibits 31: Five forces analysis - Comparison between 2024 and 2029
Exhibits 32: Bargaining power of buyers - Impact of key factors 2024 and 2029
Exhibits 33: Bargaining power of suppliers - Impact of key factors in 2024 and 2029
Exhibits 34: Threat of new entrants - Impact of key factors in 2024 and 2029
Exhibits 35: Threat of substitutes - Impact of key factors in 2024 and 2029
Exhibits 36: Threat of rivalry - Impact of key factors in 2024 and 2029
Exhibits 37: Chart on Market condition - Five forces 2024 and 2029
Exhibits 38: Chart on Product - Market share 2024-2029 (%)
Exhibits 39: Data Table on Product - Market share 2024-2029 (%)
Exhibits 40: Chart on Comparison by Product
Exhibits 41: Data Table on Comparison by Product
Exhibits 42: Chart on Anticholinergics - Market size and forecast 2024-2029 ($ million)
Exhibits 43: Data Table on Anticholinergics - Market size and forecast 2024-2029 ($ million)
Exhibits 44: Chart on Anticholinergics - Year-over-year growth 2024-2029 (%)
Exhibits 45: Data Table on Anticholinergics - Year-over-year growth 2024-2029 (%)
Exhibits 46: Chart on Beta-3 adrenergic agonists - Market size and forecast 2024-2029 ($ million)
Exhibits 47: Data Table on Beta-3 adrenergic agonists - Market size and forecast 2024-2029 ($ million)
Exhibits 48: Chart on Beta-3 adrenergic agonists - Year-over-year growth 2024-2029 (%)
Exhibits 49: Data Table on Beta-3 adrenergic agonists - Year-over-year growth 2024-2029 (%)
Exhibits 50: Chart on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 51: Data Table on Others - Market size and forecast 2024-2029 ($ million)
Exhibits 52: Chart on Others - Year-over-year growth 2024-2029 (%)
Exhibits 53: Data Table on Others - Year-over-year growth 2024-2029 (%)
Exhibits 54: Market opportunity by Product ($ million)
Exhibits 55: Data Table on Market opportunity by Product ($ million)
Exhibits 56: Chart on Distribution Channel - Market share 2024-2029 (%)
Exhibits 57: Data Table on Distribution Channel - Market share 2024-2029 (%)
Exhibits 58: Chart on Comparison by Distribution Channel
Exhibits 59: Data Table on Comparison by Distribution Channel
Exhibits 60: Chart on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 61: Data Table on Retail pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 62: Chart on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 63: Data Table on Retail pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 64: Chart on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 65: Data Table on Hospital pharmacies - Market size and forecast 2024-2029 ($ million)
Exhibits 66: Chart on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 67: Data Table on Hospital pharmacies - Year-over-year growth 2024-2029 (%)
Exhibits 68: Chart on Online - Market size and forecast 2024-2029 ($ million)
Exhibits 69: Data Table on Online - Market size and forecast 2024-2029 ($ million)
Exhibits 70: Chart on Online - Year-over-year growth 2024-2029 (%)
Exhibits 71: Data Table on Online - Year-over-year growth 2024-2029 (%)
Exhibits 72: Market opportunity by Distribution Channel ($ million)
Exhibits 73: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits 74: Chart on Disease Type - Market share 2024-2029 (%)
Exhibits 75: Data Table on Disease Type - Market share 2024-2029 (%)
Exhibits 76: Chart on Comparison by Disease Type
Exhibits 77: Data Table on Comparison by Disease Type
Exhibits 78: Chart on Idiopathic overactive bladder - Market size and forecast 2024-2029 ($ million)
Exhibits 79: Data Table on Idiopathic overactive bladder - Market size and forecast 2024-2029 ($ million)
Exhibits 80: Chart on Idiopathic overactive bladder - Year-over-year growth 2024-2029 (%)
Exhibits 81: Data Table on Idiopathic overactive bladder - Year-over-year growth 2024-2029 (%)
Exhibits 82: Chart on Neurogenic overactive bladder - Market size and forecast 2024-2029 ($ million)
Exhibits 83: Data Table on Neurogenic overactive bladder - Market size and forecast 2024-2029 ($ million)
Exhibits 84: Chart on Neurogenic overactive bladder - Year-over-year growth 2024-2029 (%)
Exhibits 85: Data Table on Neurogenic overactive bladder - Year-over-year growth 2024-2029 (%)
Exhibits 86: Market opportunity by Disease Type ($ million)
Exhibits 87: Data Table on Market opportunity by Disease Type ($ million)
Exhibits 88: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 89: Chart on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 90: Data Table on Market share By Geographical Landscape 2024-2029 (%)
Exhibits 91: Chart on Geographic comparison
Exhibits 92: Data Table on Geographic comparison
Exhibits 93: Chart on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 94: Data Table on North America - Market size and forecast 2024-2029 ($ million)
Exhibits 95: Chart on North America - Year-over-year growth 2024-2029 (%)
Exhibits 96: Data Table on North America - Year-over-year growth 2024-2029 (%)
Exhibits 97: Chart on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 98: Data Table on Europe - Market size and forecast 2024-2029 ($ million)
Exhibits 99: Chart on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 100: Data Table on Europe - Year-over-year growth 2024-2029 (%)
Exhibits 101: Chart on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 102: Data Table on Asia - Market size and forecast 2024-2029 ($ million)
Exhibits 103: Chart on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 104: Data Table on Asia - Year-over-year growth 2024-2029 (%)
Exhibits 105: Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 106: Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
Exhibits 107: Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 108: Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
Exhibits 109: Chart on US - Market size and forecast 2024-2029 ($ million)
Exhibits 110: Data Table on US - Market size and forecast 2024-2029 ($ million)
Exhibits 111: Chart on US - Year-over-year growth 2024-2029 (%)
Exhibits 112: Data Table on US - Year-over-year growth 2024-2029 (%)
Exhibits 113: Chart on China - Market size and forecast 2024-2029 ($ million)
Exhibits 114: Data Table on China - Market size and forecast 2024-2029 ($ million)
Exhibits 115: Chart on China - Year-over-year growth 2024-2029 (%)
Exhibits 116: Data Table on China - Year-over-year growth 2024-2029 (%)
Exhibits 117: Chart on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 118: Data Table on Germany - Market size and forecast 2024-2029 ($ million)
Exhibits 119: Chart on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 120: Data Table on Germany - Year-over-year growth 2024-2029 (%)
Exhibits 121: Chart on India - Market size and forecast 2024-2029 ($ million)
Exhibits 122: Data Table on India - Market size and forecast 2024-2029 ($ million)
Exhibits 123: Chart on India - Year-over-year growth 2024-2029 (%)
Exhibits 124: Data Table on India - Year-over-year growth 2024-2029 (%)
Exhibits 125: Chart on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 126: Data Table on UK - Market size and forecast 2024-2029 ($ million)
Exhibits 127: Chart on UK - Year-over-year growth 2024-2029 (%)
Exhibits 128: Data Table on UK - Year-over-year growth 2024-2029 (%)
Exhibits 129: Chart on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 130: Data Table on Canada - Market size and forecast 2024-2029 ($ million)
Exhibits 131: Chart on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 132: Data Table on Canada - Year-over-year growth 2024-2029 (%)
Exhibits 133: Chart on France - Market size and forecast 2024-2029 ($ million)
Exhibits 134: Data Table on France - Market size and forecast 2024-2029 ($ million)
Exhibits 135: Chart on France - Year-over-year growth 2024-2029 (%)
Exhibits 136: Data Table on France - Year-over-year growth 2024-2029 (%)
Exhibits 137: Chart on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 138: Data Table on Japan - Market size and forecast 2024-2029 ($ million)
Exhibits 139: Chart on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 140: Data Table on Japan - Year-over-year growth 2024-2029 (%)
Exhibits 141: Chart on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 142: Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
Exhibits 143: Chart on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 144: Data Table on Brazil - Year-over-year growth 2024-2029 (%)
Exhibits 145: Chart on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 146: Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
Exhibits 147: Chart on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 148: Data Table on South Korea - Year-over-year growth 2024-2029 (%)
Exhibits 149: Market opportunity By Geographical Landscape ($ million)
Exhibits 150: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 151: Impact of drivers and challenges in 2024 and 2029
Exhibits 152: Overview on criticality of inputs and factors of differentiation
Exhibits 153: Overview on factors of disruption
Exhibits 154: Impact of key risks on business
Exhibits 155: Companies covered
Exhibits 156: Company ranking index
Exhibits 157: Matrix on companies position and classification
Exhibits 158: AbbVie Inc. - Overview
Exhibits 159: AbbVie Inc. - Product / Service
Exhibits 160: AbbVie Inc. - Key news
Exhibits 161: AbbVie Inc. - Key offerings
Exhibits 162: SWOT
Exhibits 163: Apotex Inc. - Overview
Exhibits 164: Apotex Inc. - Product / Service
Exhibits 165: Apotex Inc. - Key news
Exhibits 166: Apotex Inc. - Key offerings
Exhibits 167: SWOT
Exhibits 168: Astellas Pharma Inc. - Overview
Exhibits 169: Astellas Pharma Inc. - Product / Service
Exhibits 170: Astellas Pharma Inc. - Key offerings
Exhibits 171: SWOT
Exhibits 172: Aurobindo Pharma Ltd. - Overview
Exhibits 173: Aurobindo Pharma Ltd. - Product / Service
Exhibits 174: Aurobindo Pharma Ltd. - Key offerings
Exhibits 175: SWOT
Exhibits 176: Axonics Inc. - Overview
Exhibits 177: Axonics Inc. - Business segments
Exhibits 178: Axonics Inc. - Key offerings
Exhibits 179: Axonics Inc. - Segment focus
Exhibits 180: SWOT
Exhibits 181: Dr Reddys Laboratories Ltd. - Overview
Exhibits 182: Dr Reddys Laboratories Ltd. - Business segments
Exhibits 183: Dr Reddys Laboratories Ltd. - Key news
Exhibits 184: Dr Reddys Laboratories Ltd. - Key offerings
Exhibits 185: Dr Reddys Laboratories Ltd. - Segment focus
Exhibits 186: SWOT
Exhibits 187: Johnson and Johnson Services Inc. - Overview
Exhibits 188: Johnson and Johnson Services Inc. - Business segments
Exhibits 189: Johnson and Johnson Services Inc. - Key news
Exhibits 190: Johnson and Johnson Services Inc. - Key offerings
Exhibits 191: Johnson and Johnson Services Inc. - Segment focus
Exhibits 192: SWOT
Exhibits 193: Lupin Ltd. - Overview
Exhibits 194: Lupin Ltd. - Business segments
Exhibits 195: Lupin Ltd. - Key news
Exhibits 196: Lupin Ltd. - Key offerings

Executive Summary

The following companies are recognized as the key players in the global overactive bladder therapeutics market: AbbVie Inc., Apotex Inc., Astellas Pharma Inc., Aurobindo Pharma Ltd., Axonics Inc., Dr Reddys Laboratories Ltd., Ferring BV, Imbrium Therapeutics L.P, Johnson and Johnson Services Inc., Lipella Pharmaceuticals Inc., Lupin Ltd., Medtronic Plc, Medytox, Merck and Co. Inc., Ono Pharmaceutical Co. Ltd., Pfizer Inc., Sumitomo Pharma Co. Ltd., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is adoption of minimally invasive treatments."

According to the report, one of the major drivers for this market is the aging population.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie Inc.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • Aurobindo Pharma Ltd.
  • Axonics Inc.
  • Dr Reddys Laboratories Ltd.
  • Ferring BV
  • Imbrium Therapeutics L.P
  • Johnson and Johnson Services Inc.
  • Lipella Pharmaceuticals Inc.
  • Lupin Ltd.
  • Medtronic Plc
  • Medytox
  • Merck and Co. Inc.
  • Ono Pharmaceutical Co. Ltd.
  • Pfizer Inc.
  • Sumitomo Pharma Co. Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Related Topics

Related Reports

Overactive Bladder Treatment Market Report 2025 - Product Image

Overactive Bladder Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Overactive Bladder Treatment Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application - Product Image

Overactive Bladder Treatment Drug Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application

  • Report
  • 96 Pages
  • Global
From
Pediatric Bladder Treatment Market Report 2025 - Product Image

Pediatric Bladder Treatment Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Overactive Bladder Treatment Market by Product Type, Therapeutic Class, Distribution Channel, Route of Administration, End User, Treatment Type, Age Group, Gender - Global Forecast to 2030 - Product Image

Overactive Bladder Treatment Market by Product Type, Therapeutic Class, Distribution Channel, Route of Administration, End User, Treatment Type, Age Group, Gender - Global Forecast to 2030

  • Report
  • 193 Pages
  • Global
From
Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report - Product Image

Overactive Bladder (OAB) Therapeutics - Global Strategic Business Report

  • Report
  • 271 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.